Activase: payments to doctors
Payments that named Activase as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 1,783
- Transactions
- 3,358
- Average per transaction
- $571
The per-transaction average — $571 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,783 providers the average total is $1,075, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genentech USA, Inc. | $1,534,150 | 80.0% |
| Genentech, Inc. | $361,256 | 18.8% |
| F. Hoffmann-la Roche AG | $21,327 | 1.1% |